JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.65B |
| 2 |
Microsoft
MSFT
|
+$2.99B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.57B |
| 5 |
ServiceNow
NOW
|
+$1.33B |
Top Sells
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.4B |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.57B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$2.55B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.15B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.56B |
Sector Composition
| 1 | Technology | 21.83% |
| 2 | Healthcare | 10.29% |
| 3 | Financials | 9.88% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Option Care Health
OPCH
$4.62B
| $29.6M | ﹤0.01% |
879,476
-34,380
| -4% | -$1.16M |
|
1352
FirstCash
FCFS
$6.49B
| $29.6M | ﹤0.01% |
273,185
-7,021
| -3% | -$761K |
|
1353
CACI
CACI
$10.9B
| $29.6M | ﹤0.01% |
91,360
-4,222
| -4% | -$1.37M |
|
1354
NRG Energy
NRG
$31.9B
| $29.5M | ﹤0.01% |
570,694
-112,759
| -16% | -$5.83M |
|
1355
H&R Block
HRB
$6.86B
| $29.5M | ﹤0.01% |
609,782
+10,194
| +2% | +$493K |
|
1356
First Trust Value Line Dividend Fund
FVD
$9.13B
| $29.5M | ﹤0.01% |
727,068
+584,511
| +410% | +$23.7M |
|
1357
Vanguard Russell 1000 Value ETF
VONV
$13.6B
| $29.5M | ﹤0.01% |
406,468
+88,541
| +28% | +$6.42M |
|
1358
Legend Biotech
LEGN
$6.11B
| $29.4M | ﹤0.01% |
489,126
+37,301
| +8% | +$2.24M |
|
1359
Service Corp International
SCI
$11.2B
| $29.4M | ﹤0.01% |
429,546
-3,936
| -0.9% | -$269K |
|
1360
First Trust NASDAQ-100 Equal Weighted Index Fund
QQEW
$1.88B
| $29.3M | ﹤0.01% |
249,707
+248,878
| +30,021% | +$29.2M |
|
1361
Invesco S&P 500 Top 50 ETF
XLG
$10.6B
| $29.3M | ﹤0.01% |
775,889
+506,244
| +188% | +$19.1M |
|
1362
Essential Properties Realty Trust
EPRT
$5.91B
| $29.1M | ﹤0.01% |
1,140,342
-67,192
| -6% | -$1.72M |
|
1363
Patterson-UTI
PTEN
$2.13B
| $29.1M | ﹤0.01% |
2,693,941
+409,313
| +18% | +$4.42M |
|
1364
CRISPR Therapeutics
CRSP
$5.12B
| $29M | ﹤0.01% |
463,270
-57,159
| -11% | -$3.58M |
|
1365
Repligen
RGEN
$6.39B
| $28.9M | ﹤0.01% |
161,004
-20,989
| -12% | -$3.77M |
|
1366
iShares US Equity Factor ETF
LRGF
$2.9B
| $28.9M | ﹤0.01% |
598,603
+102,052
| +21% | +$4.93M |
|
1367
Vanguard Total World Stock ETF
VT
$52.7B
| $28.9M | ﹤0.01% |
280,916
+234,554
| +506% | +$24.1M |
|
|
NBIS
1368
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.6B
| $28.9M | ﹤0.01% |
1,519,669
+3,309
| +0.2% | +$62.9K |
|
1369
CVB Financial
CVBF
$2.77B
| $28.9M | ﹤0.01% |
1,429,658
+310,550
| +28% | +$6.27M |
|
|
VERV
1370
DELISTED
Verve Therapeutics
VERV
| $28.7M | ﹤0.01% |
2,058,399
-447,497
| -18% | -$6.24M |
|
1371
Amdocs
DOX
$9.35B
| $28.6M | ﹤0.01% |
324,921
-14,694
| -4% | -$1.29M |
|
1372
Lear
LEA
$5.62B
| $28.5M | ﹤0.01% |
202,155
+19,524
| +11% | +$2.76M |
|
1373
Darling Ingredients
DAR
$4.97B
| $28.5M | ﹤0.01% |
572,100
-41,916
| -7% | -$2.09M |
|
1374
Palantir
PLTR
$407B
| $28.4M | ﹤0.01% |
1,652,958
-1,327,966
| -45% | -$22.8M |
|
1375
Weatherford International
WFRD
$4.48B
| $28.3M | ﹤0.01% |
289,686
-63,581
| -18% | -$6.22M |
|